Keith A A Fox

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Atrial Fibrillation

Peripheral Artery Disease

Oral Anticoagulants

Top Venues

Journal of the American Heart Association

Nature medicine

European heart journal

This page only lists publications with an associated author ORCID identifier.

Publications

Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, Guenter Breithardt, Jonathan L Halperin, Graeme J Hankey, Richard C Becker, Christopher C Nessel, Scott D Berkowitz, Keith A A Fox, Daniel E Singer, Shaun G Goodman, Manesh R Patel, Jonathan P Piccini
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal of the American Heart Association 13 (11) (2024)
Jeffrey I Weitz, László B Tankó, Jürgen Floege, Keith A A Fox, Deepak L Bhatt, Ravi Thadhani, James Hung, Ákos F Pap, Dagmar Kubitza, Wolfgang C Winkelmayer, null null
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial. Nature medicine 30 (2) (2024)
Jeffrey I Weitz, László B Tankó, Jürgen Floege, Keith A A Fox, Deepak L Bhatt, Ravi Thadhani, James Hung, Ákos F Pap, Dagmar Kubitza, Wolfgang C Winkelmayer, null null
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial. Nature medicine 30 (2) (2024)
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, Guenter Breithardt, Jonathan L Halperin, Graeme J Hankey, Richard C Becker, Christopher C Nessel, Scott D Berkowitz, Keith A A Fox, Daniel E Singer, Shaun G Goodman, Manesh R Patel, Jonathan P Piccini
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal of the American Heart Association 13 (11) (2024)
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, Guenter Breithardt, Jonathan L Halperin, Graeme J Hankey, Richard C Becker, Christopher C Nessel, Scott D Berkowitz, Keith A A Fox, Daniel E Singer, Shaun G Goodman, Manesh R Patel, Jonathan P Piccini
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal of the American Heart Association 13 (11) (2024)
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, Guenter Breithardt, Jonathan L Halperin, Graeme J Hankey, Richard C Becker, Christopher C Nessel, Scott D Berkowitz, Keith A A Fox, Daniel E Singer, Shaun G Goodman, Manesh R Patel, Jonathan P Piccini
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal of the American Heart Association 13 (11) (2024)
Alexander Breitenstein, Alain Gay, Kai Vogtländer, Keith A A Fox, Jan Steffel, null null
The Net Clinical Outcome of Dual-Pathway Inhibition in Clinical Practice: The "Xarelto plus Acetylsalicylic Acid: Treatment Patterns and Outcomes in Patients with Atherosclerosis" Registry. Journal of clinical medicine 13 (7) (2024)
Jeffrey I Weitz, László B Tankó, Jürgen Floege, Keith A A Fox, Deepak L Bhatt, Ravi Thadhani, James Hung, Ákos F Pap, Dagmar Kubitza, Wolfgang C Winkelmayer, null null
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial. Nature medicine 30 (2) (2024)
Alexander Breitenstein, Alain Gay, Kai Vogtländer, Keith A A Fox, Jan Steffel, null null
The Net Clinical Outcome of Dual-Pathway Inhibition in Clinical Practice: The "Xarelto plus Acetylsalicylic Acid: Treatment Patterns and Outcomes in Patients with Atherosclerosis" Registry. Journal of clinical medicine 13 (7) (2024)
Jeffrey I Weitz, László B Tankó, Jürgen Floege, Keith A A Fox, Deepak L Bhatt, Ravi Thadhani, James Hung, Ákos F Pap, Dagmar Kubitza, Wolfgang C Winkelmayer, null null
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial. Nature medicine (2024)
Jeffrey I Weitz, László B Tankó, Jürgen Floege, Keith A A Fox, Deepak L Bhatt, Ravi Thadhani, James Hung, Ákos F Pap, Dagmar Kubitza, Wolfgang C Winkelmayer, null null
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial. Nature medicine 30 (2) (2024)
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, Guenter Breithardt, Jonathan L Halperin, Graeme J Hankey, Richard C Becker, Christopher C Nessel, Scott D Berkowitz, Keith A A Fox, Daniel E Singer, Shaun G Goodman, Manesh R Patel, Jonathan P Piccini
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal of the American Heart Association (2024)
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, Guenter Breithardt, Jonathan L Halperin, Graeme J Hankey, Richard C Becker, Christopher C Nessel, Scott D Berkowitz, Keith A A Fox, Daniel E Singer, Shaun G Goodman, Manesh R Patel, Jonathan P Piccini
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal of the American Heart Association 13 (11) (2024)
Florian A Wenzl, Keith A A Fox, Thomas Felix Lüscher
Towards personalized cardiovascular care: Global Registry of Acute Coronary Events 3.0 score heralds artificial intelligence era. European heart journal (2023)
Josephine Harrington, Anthony P Carnicelli, Kaiyuan Hua, Lars Wallentin, Manesh R Patel, Stefan H Hohnloser, Robert P Giugliano, Keith A A Fox, Ziad Hijazi, Renato Deláscio Lopes, Sean D Pokorney, Hwanhee Hong, Christopher B Granger
Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF. Circulation (2023)
Anthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, John Eikelboom, Robert P Giugliano, David A Morrow, Manesh R Patel, Lars Wallentin, John H Alexander, Maria Cecilia Bahit, Alexander P Benz, Erin A Bohula, Tze-Fan Chao, Leanne Dyal, Michael D Ezekowitz, Keith A A Fox, Baris Gencer, Jonathan L Halperin, Ziad Hijazi, Stefan H Hohnloser, Kaiyuan Hua, Elaine Hylek, Eri Toda Kato, Julia Kuder, Renato Deláscio Lopes, Kenneth W Mahaffey, Jonas Oldgren, Jonathan P Piccini, Christian T Ruff, Jan Steffel, Daniel Wojdyla, Christopher B Granger, null null
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex. Circulation 145 (4) (2022)
Nana Pogosova, Jacqueline Bosch, Deepak L Bhatt, Keith A A Fox, Stuart J Connolly, Marco Alings, Peter Verhamme, Eva Muehlhofer, Olga Shestakovska, Salim Yusuf, John William Eikelboom
Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis. Circulation 145 (25) (2022)
Keith A A Fox, Saverio Virdone, Jean-Pierre Bassand, A John Camm, Shinya Goto, Samuel Z Goldhaber, Sylvia Haas, Gloria Kayani, Yukihiro Koretsune, Frank Misselwitz, Seil Oh, Jonathan P Piccini, Alex Parkhomenko, Jitendra Pal Singh Sawhney, Janina Stepinska, Alexander G G Turpie, Freek W A Verheugt, Ajay K Kakkar, null null
Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry. BMJ open 12 (1) (2022)
Sonia S Anand, Will Hiatt, Leanne Dyal, Rupert M Bauersachs, Scott D Berkowitz, Kelley R H Branch, Sebastian Debus, Keith A A Fox, Yan Liang, Eva Muehlhofer, Mark R Nehler, Lloyd P Haskell, Manesh Patel, Michael Szarek, Salim Yusuf, John William Eikelboom, Marc P Bonaca
Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials. European journal of preventive cardiology (2021)
John D Hung, Andreas Roos, Erik Kadesjö, David A McAllister, Dorien M Kimenai, Anoop S V Shah, Atul Anand, Fiona E Strachan, Keith A A Fox, Nicholas L Mills, Nicholas L Mills, Martin J Holzmann
Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction. European heart journal 42 (26) (2021)
Anthony P Carnicelli, Anne S Hellkamp, Kenneth W Mahaffey, Daniel E Singer, Guenter Breithardt, Jonathan L Halperin, Graeme J Hankey, Jonathan P Piccini, Richard C Becker, Christopher C Nessel, Scott D Berkowitz, Keith A A Fox, Robert M Califf, Manesh R Patel
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial. Journal of the American Heart Association 10 (19) (2021)
Davide Capodanno, Deepak L Bhatt, John W Eikelboom, Keith A A Fox, Tobias Geisler, Charles Michael Gibson, Jose Ramon Gonzalez-Juanatey, Stefan James, Renato D Lopes, Roxana Mehran, Gilles Montalescot, Manesh Patel, P Gabriel Steg, Robert F Storey, Pascal Vranckx, Jeffrey I Weitz, Robert Welsh, Uwe Zeymer, Dominick J Angiolillo
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease. Nature reviews. Cardiology 17 (4) (2020)
Keith A A Fox, Marco Metra, João Morais, Dan Atar
The myth of 'stable' coronary artery disease. Nature reviews. Cardiology 17 (1) (2019)